Equitable Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $276K | Hold |
525
| – | – | 0.01% | 392 |
|
|
2025
Q1 | $333K | Hold |
525
| – | – | 0.02% | 386 |
|
|
2024
Q4 | $374K | Hold |
525
| – | – | 0.02% | 377 |
|
|
2024
Q3 | $552K | Sell |
525
-306
| -37% | -$322K | 0.04% | 295 |
|
|
2024
Q2 | $873K | Buy |
+831
| New | +$873K | 0.06% | 214 |
|
|
2022
Q4 | – | Sell |
-645
| Closed | -$445K | – | 416 |
|
|
2022
Q3 | $445K | Hold |
645
| – | – | 0.04% | 264 |
|
|
2022
Q2 | $381K | Hold |
645
| – | – | 0.03% | 292 |
|
|
2022
Q1 | $451K | Hold |
645
| – | – | 0.03% | 266 |
|
|
2021
Q4 | $408K | Sell |
645
-750
| -54% | -$474K | 0.03% | 284 |
|
|
2021
Q3 | $844K | Sell |
1,395
-106
| -7% | -$64.1K | 0.05% | 193 |
|
|
2021
Q2 | $838K | Sell |
1,501
-262
| -15% | -$146K | 0.05% | 199 |
|
|
2021
Q1 | $834K | Sell |
1,763
-8,589
| -83% | -$4.06M | 0.06% | 186 |
|
|
2020
Q4 | $5M | Sell |
10,352
-311
| -3% | -$150K | 0.37% | 75 |
|
|
2020
Q3 | $5.97M | Sell |
10,663
-353
| -3% | -$198K | 0.51% | 55 |
|
|
2020
Q2 | $6.87M | Sell |
11,016
-336
| -3% | -$210K | 0.63% | 48 |
|
|
2020
Q1 | $5.54M | Buy |
11,352
+513
| +5% | +$250K | 0.61% | 47 |
|
|
2019
Q4 | $4.07M | Buy |
10,839
+933
| +9% | +$350K | 0.4% | 69 |
|
|
2019
Q3 | $2.75M | Buy |
9,906
+441
| +5% | +$122K | 0.29% | 85 |
|
|
2019
Q2 | $2.96M | Buy |
9,465
+1,255
| +15% | +$393K | 0.31% | 85 |
|
|
2019
Q1 | $3.37M | Sell |
8,210
-120
| -1% | -$49.3K | 0.39% | 75 |
|
|
2018
Q4 | $3.11M | Buy |
8,330
+246
| +3% | +$91.9K | 0.41% | 72 |
|
|
2018
Q3 | $3.27M | Sell |
8,084
-111
| -1% | -$44.8K | 0.38% | 78 |
|
|
2018
Q2 | $2.83M | Buy |
+8,195
| New | +$2.83M | 0.36% | 85 |
|